Enantioselective synthesis of azetidinone intermediate compounds

Details for Australian Patent Application No. 2002258605 (hide)

International Classifications

Event Publications

3 April 2003 Application Open to Public Inspection

Published as AU-B-2002258605

12 January 2006 Application Accepted

Published as AU-B-2002258605

11 May 2006 Standard Patent Sealed

11 October 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2002311841 3,4-di-substituted cyclobutene-1,2-diones as cxcchemokine receptor ligands Pharmacopeia, Inc. ; Schering Corporation The nature of the amendment is: Amend the Patentee to read Pharmacopeia, Inc. and Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Mil

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.